Diese Webseite nutzt Cookies

Diese Webseite nutzt Cookies zur Verbesserung des Erlebnisses unserer Besucher. Indem Sie weiterhin auf dieser Webseite navigieren, erklären Sie sich mit unserer Verwendung von Cookies einverstanden.

Essenzielle Cookies ermöglichen grundlegende Funktionen und sind für die einwandfreie Funktion der Website erforderlich.
Statistik Cookies erfassen Informationen anonym. Diese Informationen helfen uns zu verstehen, wie unsere Besucher unsere Website nutzen.
Marketing-Cookies werden von Drittanbietern oder Publishern verwendet, um personalisierte Werbung anzuzeigen. Sie tun dies, indem sie Besucher über Websites hinweg verfolgen.

Don’t miss out on expert speakers
discussing Targeted Radionuclide
Therapy at ENETS 2023

ENETS 2023

I am a healthcare professional

This site is intended for healthcare professionals only.

Click here

I am a member of the public

 
 

Click here Go to home

Our Mission

We aim to provide the most precise cancer radiodiagnostics and therapeutics to fight hard-to-treat tumors. With improved patient benefit as the driving principle for all we do, ITM advances a broad precision oncology pipeline, including two phase III studies, combining the company’s high-quality radioisotopes with a range of targeting molecules. We are leveraging our radioisotope leadership to advance a broad pipeline of Targeted Radionuclide Therapies for helping patients live longer and better.

Watch the introduction below and register now to access all of our recordings from ENETS 2023

All of the speakers' videos and presentations are available online upon registration.

A short story of NET therapy – from cold to hot somatostatin
Prof. Kjell Öberg, Professor of Endocrine Oncology, Uppsala University, Finland

We look back on a truly enlightening and sucessful ENETS 2023 conference. We will inform you once the ITM satellite content is available.

Meet the change-makers

Kjell Öberg

Professor, Endocrine Oncology

Senior Professor, Dept of Medical Sciences

Senior Advisor, Dept of Endocrine Oncology - University Hospital

Uppsala University

Aldo Scarpa

Director, ARC-Net Research Centre for Applied Research on Cancer

Director, Dept of Pathology

University and Hospital Trust of Verona

Wolfgang A. Weber

Chair, Dept of Nuclear Medicine

Full Professor, Nuclear Medicine

Technical University of Munich

Heloisa Soares

Associate Professor, Huntsman Cancer Institute

University of Utah